Albemarle's stock price soared 5.12% during intraday trading on Monday, reflecting strong positive momentum in the market.

The significant upward move appears driven by bullish analyst sentiment, with several prominent firms raising their price targets for the company. RBC Capital increased its target to $253 from $245 while maintaining an Outperform rating. Separately, Argus Research raised its target to $230 from $185, and Jefferies lifted its target to $244 from $230.

These consecutive upward revisions from multiple analysts suggest growing confidence in Albemarle's business prospects and financial outlook, which likely contributed to the substantial buying pressure and price appreciation observed during the trading session.